BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elbahrawy A, Ibrahim MK, Eliwa A, Alboraie M, Madian A, Aly HH. Current situation of viral hepatitis in Egypt. Microbiol Immunol 2021;65:352-72. [PMID: 33990999 DOI: 10.1111/1348-0421.12916] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 El-attar EA, Helmy Elkaffas RM, Aglan SA, Naga IS, Nabil A, Abdallah HY. Genomics in Egypt: Current Status and Future Aspects. Front Genet 2022;13:797465. [DOI: 10.3389/fgene.2022.797465] [Reference Citation Analysis]
2 Elbrolosy AM, Elabd NS, ElGedawy GA, Abozeid M, Abdelkreem M, Montaser B, Eed EM, Elhamouly MS. Toll- like receptor 2 polymorphism and IL-6 profile in relation to disease progression in chronic HBV infection: a case control study in Egyptian patients. Clin Exp Med 2022. [PMID: 35119591 DOI: 10.1007/s10238-022-00792-6] [Reference Citation Analysis]
3 Samaan E, El-etreby S, Ahmed A, El-husseini F, Sabry A. The nature and prognosis of renal diseases in chronic hepatitis-C-infected diabetic Egyptian patients: The role of renal biopsy. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2022;16:102368. [DOI: 10.1016/j.dsx.2021.102368] [Reference Citation Analysis]
4 Kim DH, Ahn HS, Go HJ, Kim DY, Kim JH, Lee JB, Park SY, Song CS, Lee SW, Choi IS. Heme Oxygenase-1 Exerts Antiviral Activity against Hepatitis A Virus In Vitro. Pharmaceutics 2021;13:1229. [PMID: 34452191 DOI: 10.3390/pharmaceutics13081229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Shahen SM, Elshenawy SZ, Mohamed SE, Talaat RM. Genetic polymorphisms in the miR-372 (rs12983273) and LncRNA HULC (rs7763881) genes and susceptibility to Hepatitis B virus (HBV) infection. Mol Biol Rep 2021;48:7901-6. [PMID: 34677712 DOI: 10.1007/s11033-021-06818-8] [Reference Citation Analysis]